Cupid (530843) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
28 Oct, 2026Executive summary
FY26 audited consolidated revenue from operations was ₹35,770.88 lakh and net profit ₹10,823.33 lakh, up 94.91% and 164.71% YoY, exceeding guidance of ₹335 Cr revenue and ₹100 Cr net profit.
Q4 FY26 was the strongest quarter on record, supported by exports, FMCG, IVD and institutional business, alongside improved operating leverage.
Standalone and consolidated auditors issued unmodified opinions; consolidated results include one foreign subsidiary whose unaudited management-prepared financials were deemed immaterial.
Financial highlights
Q4 FY26 revenue from operations was ₹11,996.17 lakh vs ₹5,648.18 lakh; net profit was ₹3,626.25 lakh vs ₹1,151.08 lakh.
Q4 FY26 EBITDA was ₹37.52 Cr vs ₹13.40 Cr, up 179.93%; EBITDA margin was 31.27% vs 23.73%.
FY26 consolidated revenue was ₹35,770.88 lakh vs ₹18,352.13 lakh; total income was ₹39,140.14 lakh vs ₹20,318.28 lakh.
FY26 EBITDA was ₹116.70 Cr vs ₹41.73 Cr; net profit was ₹108.23 Cr vs ₹40.89 Cr. FY26 consolidated PBT was ₹14,246.56 lakh vs ₹5,485.94 lakh.
FY26 fair-value investment income was ₹13,204.36 lakh vs ₹10,438.17 lakh and contributed substantially to total income.
Outlook and guidance
FY27 targets are ₹600 Cr revenue and ₹180 Cr net profit; FY28 targets are ₹875 Cr and ₹275 Cr, and FY29 targets are ₹1,150 Cr and ₹390 Cr, respectively.
Baazar Style Retail access is expected to generate ₹150 Cr incremental revenue in FY27 and scale to ₹500 Cr annually over the medium term.
Growth drivers include FMCG distribution, core-product capacity expansion, higher-margin B2C mix, new wellness products, institutional business and operating leverage.
Global footprint targeted to expand 35% over the next year, supported by partnerships, deeper market penetration and tenders.
Latest events from Cupid
- Port delays constrained Q3 female condom sales; major capital actions were proposed.530843
Q3 23/24 - Q1 net profit reached ₹825.51 lakh as plans advanced for a wholly owned UAE subsidiary.530843
Q1 24/25 - FY revenue and profit rose; contraceptives led while IVD losses narrowed.530843
Q4 23/24 - Q2 profit nearly doubled YoY as H1 revenue and net profit advanced.530843
Q2 24/25 - FY25 revenue and profit rose, but operating cash flow turned negative.530843
Q4 24/25 - Q3 profit rose YoY as a new UAE subsidiary advanced Gulf expansion.530843
Q3 24/25 - Q1 FY26 revenue and consolidated net profit rose YoY; basic EPS reached ₹0.56.530843
Q1 25/26 - Q2 net profit reached ₹2,411.56 lakh; expired warrants caused no equity dilution.530843
Q2 25/26 - Q3 profit rose alongside a proposed 4:1 bonus issue, pending approvals.530843
Q3 25/26